glp-1 drugs for insulin resistance Prevention: Using Like Zepbound for Pre-Diabetes or Metabolic Risk -What Does Research Say? The Role of Glp-1 Receptor

Background: The evidence on berberine stimulating the secretion of GLP-1 in intestinal L cell has been studied

These medications also delay gastric emptying through neural mechanisms, increasing the risk for perioperative aspiration during anaesthesia and sedation

GLP-1 drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and orforglipron (Foundayo) offer promising results for weight loss and health.

The first GLP-1 receptor agonist entered clinical use in 2005, marking a paradigm shift in metabolic disease treatment

Ozempic and other GLP-1 receptor agonists can increase insulin secretion, suppress glucagon release, slow digestion, and more

Explore the differences in GLP-1 patches vs injections and pills